Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Toronto (Dec. 10, 2006) - Drs. Gordon Keller, Igor Jurisica, Thomas Kislinger, Shuzo Sugita and Elisabeth Tillier (pictured clockwise from top left) were awarded a total of $3.4M on December 7 from the Canada Research Chairs (CRC) program--a strategy initiated by the government of Canada to attract and retain the world's most accomplished and promising minds.
Embryonic stem cell biologist and new McEwen Centre Director Dr. Keller won a new Tier I CRC, which is awarded to outstanding researchers acknowledged by their peers as world leaders in their fields.
Drs. Jurisica, Kislinger and Tillier received new Tier II CRCs--given to exceptional emerging researchers, acknowledged by their peers as having the potential to lead in their field--and Dr. Sugita's existing Tier II CRC was successfully renewed. Their awards will support their programs in integrative computational biology (Dr. Jurisica), proteomics in cancer research (Dr. Kislinger), intercellular communication (Dr. Sugita) and analytical genomics (Dr. Tillier).
Drs. Jurisica, Keller and Kislinger were awarded a further $1M in infrastructure funding associated with their CRC awards from the Canada Foundation for Innovation, bringing the UHN awards announced this week to $4.4M total.
Phone: 416 340 4636